DIBEKACIN
UNII 45ZFO9E525

Substance Identification & Data

This profile provides standardized clinical and technical data for Dibekacin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 45ZFO9E525.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 34493-98-6 and the RxNorm Concept ID (RxCUI) 3328. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

45ZFO9E525

CAS Registry Number

34493-98-6

RxNorm Concept ID

3328

Detailed Substance Profile

Preferred Name

DIBEKACIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H37N5O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JJCQSGDBDPYCEO-XVZSLQNASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C79114

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

470999

Unique identification number in the NCBI database of chemical substances.

INN ID

3610

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H]1(O[C@@]2([C@H]([C@](O[C@@H]3[C@@H](CC[C@H](O3)CN)N)([C@H](C[C@H]2N)N)[H])O)[H])[C@H](O)[C@H]([C@@H]([C@@H](CO)O1)O)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dibekacin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.